Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » ISOPP

ISOPP

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 27/04/20 by Bastiaan Buijtenhuijs

The use of GCSF to reduce the incidence of febrile neutropenia in patients receiving Docetaxel for Castrate resistant prostate cancer

View resources
Last reviewed: 27/04/20 by Huan L

Traditional Chinese medicine use in oncology settings: a questionnaire survey

View resources
Last reviewed: 27/04/20 by Yu Ke

Utilization of chronic disease medications in early-stage breast cancer survivors: an observational study

View resources
Last reviewed: 27/04/20 by Jennifer Allison

What patient assessment skills are required by pharmacists prescribing systemic anti-cancer therapy? A consensus study.

View resources
Last reviewed: 27/04/20 by Beth V. Clayton

When is it acceptable to allow a terminal patient to die? A cross sectional study with UK pharmacy students

View resources
Last reviewed: 27/04/20 by Rehnuma Badat

A case study of a patient with pre-existing interstitial lung disease treated with pembrolizumab

View resources
Last reviewed: 27/04/20 by Kimberley-Ann Kerr

A comparative audit of the treatment and management of febrile neutropenia

View resources
Last reviewed: 27/04/20 by Esin Aysel Kandemir

A pharmacist’s involvement in identifying anticoagulants-related problems in patients with cancer

View resources
Last reviewed: 27/04/20 by Linet C. Kugo

A pharmacy led pharmacovigilance program for multiple myeloma patients at Moi Teaching and Referral Hospital: a 5 year experience

View resources
Last reviewed: 27/04/20 by Lynne Nakashima

A real world data approach to determine the optimal dosing strategy for pembrolizumab

View resources
Last reviewed: 17/03/21 by Bastiaan Buijtenhuijs

Improving efficiency, patient safety and reducing wastage through a first in Europe chemotherapy eOrdering interface

Abstracts

View resources
Last reviewed: 27/04/20 by Alvaro N. Machado

Increasing pharmaceutical care offer by implementing process improvement methodologies in an outpatient oncology infusion unit

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 7 8 9 … 13 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.